| Latest on CP Wire |
|---|
| “Special Fraud Alert” Targets Pharma & Medical Device Speaker Programs |
| Fri, 11/20/20 - 10:48 am |
| Launch of Unprecedented Biotech Data Resource |
| Thu, 11/12/20 - 10:09 am |
| Bigfinite is Now Aizon |
| Mon, 10/5/20 - 02:43 pm |
| SIFI reports positive results from 044/si phase 3 clinical trial further highlighting strength of its NETILDEX® franchise |
| Tue, 08/25/20 - 01:22 pm |
| Highlights: 2020 Cardiometabolic Health Congress West Live Online |
| Fri, 08/21/20 - 12:25 am |
| Chelation Partners Announces Issuance of U.S. Patent Covering Composition of Matter for DIBI and Related Compounds for Controlling Infections |
| Mon, 08/3/20 - 09:59 am |
| How Contingency Fee Arrangements Empower Whistleblowers |
| Wed, 06/24/20 - 10:42 am |
| COVID-19 Employment and Whistleblower Issues - Interview With an Employment Attorney |
| Wed, 06/3/20 - 11:01 am |
| Active Symptom Monitoring Won’t be Effective in Controlling Spread of COVID-19 Once World Returns to “New Normal,” Study Suggests |
| Tue, 06/2/20 - 04:48 pm |
| Cybersecurity, Pharma, and Whistleblowing |
| Fri, 05/15/20 - 03:56 pm |
|
| rssfeedwidget.com |